Final dividend Royal DSM N.V.
(Thomson Reuters ONE) -
The DSM Annual General Meeting of Shareholders on 28 April 2011 passed a
resolution to declare a dividend for 2010 of ? 1.35 per ordinary share of ?
1.50 par value. An interim dividend of ? 0.40 per ordinary share having been
paid on 27 August 2010, the final dividend for 2010 will amount to ? 0.95 per
ordinary share.
This final dividend of ? 0.95 will be paid out in cash or in the form of
ordinary shares at the option of the shareholder. Dividend in cash will be paid
after deduction of 15% Dutch dividend withholding tax. The ex-dividend date on
NYSE Euronext will be 2 May 2011 and the record date will be 4 May 2011.
Shareholders have from 5 May until 20 May 2011 (3.00 pm CET) to indicate their
choice. On 20 May 2011 after the close of trading on NYSE Euronext the number of
dividend rights of ordinary shares entitling the holder to one ordinary share
will be determined.
This exchange ratio will be based on the volume weighted average price of all
ordinary shares in DSM traded at NYSE Euronext on 16, 17, 18, 19 and 20 May
2011. The value of the stock dividend will be virtually equal to the value of
the cash dividend. The ordinary shares that constitute the stock dividend are
entitled to any dividend for the financial year 2011 and to the dividends for
subsequent financial years. Stock dividend rights will not be traded on NYSE
Euronext.
The following timetable applies:
2 May 2011: Ex-dividend quotation
4 May 2011: Record Date
5 May 2011 - 20 May 2011(3.00 pm CET): Period in which shareholders can
indicate their choice
23 May 2011 (COB): Announcement of the exchange
ratio
25 May 2011: Delivery of shares or cash
payment
DSM - Bright Science. Brighter Living.(TM)
Royal DSM N.V. is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and Materials
Sciences DSM is driving economic prosperity, environmental progress and social
advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in global
markets such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials. DSM's
22,000 employees deliver annual net sales of about ? 9 billion. The company is
listed on NYSE Euronext. More information can be found at www.dsm.com
For more information:
DSM Corporate Communications DSM Investor Relations
Herman Betten Hans Vossen
tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864
fax +31 (0) 45 5740680 fax +31 (0) 10 4590275
e-mail media.relations(at)dsm.com e-mail investor.relations(at)dsm.com
Press release-pdf:
http://hugin.info/130663/R/1510441/445471.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE
[HUG#1510441]
Unternehmensinformation / Kurzprofil:
Datum: 28.04.2011 - 18:15 Uhr
Sprache: Deutsch
News-ID 54029
Anzahl Zeichen: 4058
contact information:
Town:
Heerlen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 168 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Final dividend Royal DSM N.V."
steht unter der journalistisch-redaktionellen Verantwortung von
DSM N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
